Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 26;10(5):e0130122.
doi: 10.1128/spectrum.01301-22. Epub 2022 Aug 18.

Assessment of the Performance of the Aptima Bacterial Vaginosis Assay Over a 3-Month Period in a French Hospital

Affiliations

Assessment of the Performance of the Aptima Bacterial Vaginosis Assay Over a 3-Month Period in a French Hospital

L Ruffier d'Epenoux et al. Microbiol Spectr. .

Abstract

Bacterial vaginosis (BV) is the most common cause of abnormal vaginal discharge. BV represents a dysbiosis with the acquisition of a diverse community of anaerobic bacteria and a reduction in lactobacilli burden. Our objective was to evaluate the Aptima BV assay kit for the diagnosis of BV. From May to August 2019, we enrolled outpatients and inpatients, including nonpregnant women above 18 with vaginosis symptoms, consulting at Nantes University hospital. The Aptima BV assay measures the loads of Gardnerella vaginalis, Atopobium vaginae, and Lactobacillus species in relation to overall bacterial load. The Aptima BV assay was compared to Nugent scoring (NS). A total of 456 women were enrolled, and 347 patients met the inclusion criteria with data available for the analysis. NS was used to classify the samples and 144 (41.5%) samples were classified as normal (NS = 0-3), 45 (13%) as BV (NS = 7-10), 38 (11%) presented an intermediate vaginal microbiota (3 < NS < 7), 79 (22.7%) had various bacteria (excluding vaginal flora), 29 (8.3%) had insufficient bacterial density, and 12 (3.5%) had a predominance of yeasts. The Aptima BV kit displayed a sensitivity of 91.1% and specificity of 94.4% with a positive predictive value (PPV) of 83.7% and a negative predictive (NPV) value of 97.1%. The results of this monocentric retrospective study show that Aptima BV kit has a good diagnostic correlation compared to standard of care for dysbiotic diagnosis cases. IMPORTANCE The possibility exists of the involvement of a new molecular test in the routine algorithm of bacterial vaginosis diagnosis in microbiology laboratories. This manuscript reports on our experience, and we propose an organization combining Nugent scoring and molecular testing, especially for intermediate Nugent scores.

Keywords: Atopobium vaginae; Gardnerella vaginalis; Lactobacillus; Nugent scoring; bacterial vaginosis; molecular test.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIG 1
FIG 1
Study flow chart of the vaginal specimens included. NS, Nugent scoring; VS, vaginal samples; BAC, vaginal samples with various bacteria (excluding vaginal flora); YE, vaginal samples with predominance of yeast; IBD, vaginal samples with insufficient bacteria density.
FIG 2
FIG 2
Proposal of an algorithm for routine BV diagnosis. NS, Nugent’s scoring.

Similar articles

Cited by

References

    1. Morris M, Nicoll A, Simms I, Wilson J, Catchpole M. 2001. Bacterial vaginosis: a public health review. BJOG 108:439–450. doi: 10.1111/j.1471-0528.2001.00124.x. - DOI - PubMed
    1. van de Wijgert JHHM, Borgdorff H, Verhelst R, Crucitti T, Francis S, Verstraelen H, Jespers V. 2014. The vaginal microbiota: what have we learned after a decade of molecular characterization? PLoS One 9:e105998. doi: 10.1371/journal.pone.0105998. - DOI - PMC - PubMed
    1. Bagnall P, Rizzolo D. 2017. Bacterial vaginosis: a practical review. JAAPA 30:15–21. doi: 10.1097/01.JAA.0000526770.60197.fa. - DOI - PubMed
    1. Taylor BD, Darville T, Haggerty CL. 2013. Does bacterial vaginosis cause pelvic inflammatory disease? Sex Transm Dis 40:117–122. doi: 10.1097/OLQ.0b013e31827c5a5b. - DOI - PubMed
    1. Sobel R, Sobel JD. 2015. Metronidazole for the treatment of vaginal infections. Expert Opin Pharmacother 16:1109–1115. doi: 10.1517/14656566.2015.1035255. - DOI - PubMed

LinkOut - more resources